Year
Number of hospitalized patients
Number and proportion (%) of infants
Number and proportion (%) of children aged 1–3 years
Number and proportion (%) of children aged 4–6 years
Number and proportion (%) of children aged >6 years
2012
1,083
545 (50 %)
346 (32 %)
144 (13 %)
48 (5 %)
2013
1,111
559 (50 %)
358 (32 %)
147 (13 %)
47 (5 %)
3 Results
The majority of patients were referred to the hospital by general practitioners or primary care pediatricians due to respiratory tract infections (RTI) (Table 2). Among RTI cases, the most common diagnoses were: pneumonia (82 %), bronchitis (10 %), bronchiolitis (2 %), tonsillitis (1 %), laryngitis (2 %), sinusitis (2 %), and otitis media (1 %). The second biggest cause of admission to the hospital was gastrointestinal infection: gastroenterocolitis of unknown etiology (51 %), gastroenterocolitis of rotavirus or adenovirus etiology (36 %), and gastroenterocolitis of bacterial etiology (13 %). After the implementation of HAP, the proportion of children with RTI treated with antibiotics significantly decreased (91 % vs. 86 %, p < 0.05). The proportions of patients receiving antibiotics for the treatment of other infections (e.g., urinary tract or gastrointestinal infections) remained unchanged (p > 0.05). The total proportion of patients treated with antibiotics was significantly reduced after the implementation of HAP (72 % vs. 65 %, p < 0.05) (Table 2).
Table 2
Reasons for hospitalization and proportions of patients receiving antibiotic therapy at the General Pediatric Ward
Year | 2012 | 2013 | 2012–2013 | 2012 | 2013 | 2012–2013 |
---|---|---|---|---|---|---|
Diagnosis | No (%) of patients receiving diagnosis | No (%) of patients receiving antibiotics | ||||
Respiratory tract infections | 603 | 607 | 1,210 | 552 | 523 | 1,075 |
(56 %) | (55 %) | (55 %) | (91 %)* | (86 %)* | (89 %) | |
Gastrointestinal infections | 327 | 378 | 705 | 93 | 102 | 195 |
(30 %) | (34 %) | (32 %) | (28 %) | (27 %) | (28 %) | |
Urinary tract infections | 99 | 76 | 175 | 99 | 76 | 175 |
(9 %) | (7 %) | (8 %) | (100 %) | (100 %) | (100 %) | |
Skin infections | 18 | 15 | 33 | 7 | 6 | 12 |
(2 %) | (1 %) | (2 %) | (38 %) | (40 %) | (36 %) | |
Sepsis | 15 | 4 | 19 | 15 | 4 | 19 |
(1 %) | (0.4 %) | (1 %) | (100 %) | (100 %) | (100 %) | |
Other infections | 12 | 14 | 26 | 8 | 9 | 18 |
(1 %) | (1 %) | (1 %) | (67 %) | (64 %) | (69 %) | |
Other reasons | 9 | 17 | 26 | 3 | 6 | 9 |
(1 %) | (2 %) | (1 %) | (33 %) | (35 %) | (35 %) | |
Total | 1,083 | 1,111 | 2,194 | 777 | 726 | 1,503 |
(100 %) | (100 %) | (100 %) | (72 %)* | (65 %)* | (68 %) |
None of the restricted antibiotics (including glycopeptides or monobactams) were used either before or after HAP’s implementation (Table 3). After implementation of HAP, a decreased use of ceftriaxone and cefuroxime was observed. The most commonly used antibiotic was amoxicillin with clavulanic acid (Table 3). The DU100% remained the same before and after implementation of HAP (8 antibiotics), while DU90% increased after implementation of HAP (5 vs. 3 antibiotics) (Table 4).
Table 3
Antibiotic consumption patterns before and after HAP’s implementation
Antibiotics for systemic use | DDDs | DDDs/100 Patient-days | DDDs/100 admissions | % of DDDs | ||||
---|---|---|---|---|---|---|---|---|
Year | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 |
Penicillin: | ||||||||
Ampicillin | 1.3 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 |
Penicillin with beta-lactamase inhibitors: | ||||||||
Amoxicillin & clavulanic acid | 739.6 | 650.6 | 12.3 | 12.2 | 68.3 | 58.6 % | 34.0 | 48.7 |
Aminoglycoside: | ||||||||
Amikacin | 103.8 | 92.3 | 1.7 | 1.7 | 9.6 | 8.3 | 4.8 | 6.9 |
2nd generation cephalosporins | ||||||||
Cefuroxime | 667.5 | 295.0 | 11.1 | 5.5 | 661.6 | 26.8 | 30.6 | 16.5 |
3rd generation cephalosporins: | ||||||||
Cefotaxime | 0.0 | 75.0 | 0.0 | 1.4 | 0.0 | 6.8 | 0.0 | 5.6 |
Ceftazidime | 7.5 | 10.0 | 0.1 | 0.2 | 0.7 | 0.8 | 0.4 | 0.7 |
Ceftriaxone
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |